• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of annrheumdAnnals of the Rheumatic DiseasesView this articleSubmit a manuscriptReceive email alertsContact usBMJ
Ann Rheum Dis. Jun 1997; 56(6): 341–342.
PMCID: PMC1752397

Dyslipidaemia and rheumatoid arthritis

Full Text

The Full Text of this article is available as a PDF (60K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Munro R, Morrison E, McDonald AG, Hunter JA, Madhok R, Capell HA. Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis. Ann Rheum Dis. 1997 Jun;56(6):374–377. [PMC free article] [PubMed]
  • Reilly PA, Cosh JA, Maddison PJ, Rasker JJ, Silman AJ. Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients. Ann Rheum Dis. 1990 Jun;49(6):363–369. [PMC free article] [PubMed]
  • Myllykangas-Luosujärvi RA, Aho K, Isomäki HA. Mortality in rheumatoid arthritis. Semin Arthritis Rheum. 1995 Dec;25(3):193–202. [PubMed]
  • Bacons PA, Kitas GD. The significance of vascular inflammation in rheumatoid arthritis. Ann Rheum Dis. 1994 Oct;53(10):621–623. [PMC free article] [PubMed]
  • Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med. 1991 Aug 8;325(6):373–381. [PubMed]
  • Winyard PG, Tatzber F, Esterbauer H, Kus ML, Blake DR, Morris CJ. Presence of foam cells containing oxidised low density lipoprotein in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis. 1993 Sep;52(9):677–680. [PMC free article] [PubMed]
  • Offermann MK, Medford RM. Antioxidants and atherosclerosis: a molecular perspective. Heart Dis Stroke. 1994 Jan-Feb;3(1):52–57. [PubMed]
  • Situnayake RD, Thurnham DI, Kootathep S, Chirico S, Lunec J, Davis M, McConkey B. Chain breaking antioxidant status in rheumatoid arthritis: clinical and laboratory correlates. Ann Rheum Dis. 1991 Feb;50(2):81–86. [PMC free article] [PubMed]
  • Lakatos J, Hárságyi A. Serum total, HDL, LDL cholesterol, and triglyceride levels in patients with rheumatoid arthritis. Clin Biochem. 1988 Apr;21(2):93–96. [PubMed]
  • Svenson KL, Lithell H, Hällgren R, Selinus I, Vessby B. Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity. Arch Intern Med. 1987 Nov;147(11):1912–1916. [PubMed]
  • Svenson KL, Lithell H, Hällgren R, Vessby B. Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. II. Effects of anti-inflammatory and disease-modifying drug treatment. Arch Intern Med. 1987 Nov;147(11):1917–1920. [PubMed]
  • Rantapä-Dahlqvist S, Wållberg-Jonsson S, Dahlén G. Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis. Ann Rheum Dis. 1991 Jun;50(6):366–368. [PMC free article] [PubMed]
  • Lazarevic MB, Vitic J, Mladenovic V, Myones BL, Skosey JL, Swedler WI. Dyslipoproteinemia in the course of active rheumatoid arthritis. Semin Arthritis Rheum. 1992 Dec;22(3):172–178. [PubMed]
  • Lip GY, Jones AF. Lipoprotein (a) and vascular disease: thrombogenesis and atherogenesis. QJM. 1995 Aug;88(8):529–539. [PubMed]
  • Wållberg-Jonsson S, Uddhammar A, Dahlén G, Rantapä-Dahlqvist S. Lipoprotein(a) in relation to acute phase reaction in patients with rheumatoid arthritis and polymyalgia rheumatica. Scand J Clin Lab Invest. 1995 Jul;55(4):309–315. [PubMed]
  • Lazarevic MB, Vitic J, Myones BL, Mladenovic V, Nanusevic N, Skosey JL, Swedler WI. Antilipoprotein antibodies in rheumatoid arthritis. Semin Arthritis Rheum. 1993 Jun;22(6):385–391. [PubMed]
  • Monson RR, Hall AP. Mortality among arthritics. J Chronic Dis. 1976 Jul;29(7):459–467. [PubMed]
  • Ettinger WH, Klinefelter HF, Kwiterovitch PO. Effect of short-term, low-dose corticosteroids on plasma lipoprotein lipids. Atherosclerosis. 1987 Feb;63(2-3):167–172. [PubMed]
  • Wallberg-Jonsson S, Ohman ML, Dahlqvist SR. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol. 1997 Mar;24(3):445–451. [PubMed]
  • Raynauld JP. Cardiovascular mortality in rheumatoid arthritis: how harmful are corticosteroids? J Rheumatol. 1997 Mar;24(3):415–416. [PubMed]
  • Vathsala A, Weinberg RB, Schoenberg L, Grevel J, Dunn J, Goldstein RA, Van Buren CT, Lewis RM, Kahan BD. Lipid abnormalities in renal transplant recipients treated with cyclosporine. Transplant Proc. 1989 Aug;21(4):3670–3673. [PubMed]
  • Wallace DJ, Metzger AL, Stecher VJ, Turnbull BA, Kern PA. Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids. Am J Med. 1990 Sep;89(3):322–326. [PubMed]
  • Beynen AC. Could chloroquine be of value in the treatment of hypercholesterolemia? Artery. 1986;13(6):340–351. [PubMed]
  • Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996 Apr;3(2):213–219. [PubMed]
  • Ramsay LE, Yeo WW, Jackson PR. Dietary reduction of serum cholesterol concentration: time to think again. BMJ. 1991 Oct 19;303(6808):953–957. [PMC free article] [PubMed]
  • Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 1994 Feb 5;308(6925):367–372. [PMC free article] [PubMed]
  • Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995 Nov 16;333(20):1301–1307. [PubMed]
  • Duncan MR, Capell HA. The use of antimalarials in combination with other disease modifying agents in RA--the British experience. Lupus. 1996 Jun;5 (Suppl 1):S50–S58. [PubMed]
  • Falkeborn M, Persson I, Adami HO, Bergström R, Eaker E, Lithell H, Mohsen R, Naessén T. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol. 1992 Oct;99(10):821–828. [PubMed]
  • Mulherin DM, Thurnham DI, Situnayake RD. Glutathione reductase activity, riboflavin status, and disease activity in rheumatoid arthritis. Ann Rheum Dis. 1996 Nov;55(11):837–840. [PMC free article] [PubMed]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...